Cargando…
Novel adjuvants and vaccine delivery systems
Conventionally the efficiency of an adjuvant is measured by the capacity to induce enhanced antibody serum titres and cell mediated immunity (CMI) to a given antigen. Nowadays the capacity of an adjuvant is also measured by the quality as well as the magnitude of the induced immune response, guided...
Autores principales: | Morein, Bror, Villacrés-Eriksson, María, Sjölander, Anders, Lövgren Bengtsson, Karin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119835/ https://www.ncbi.nlm.nih.gov/pubmed/8988882 http://dx.doi.org/10.1016/S0165-2427(96)05697-8 |
Ejemplares similares
-
The adjuvant G3 promotes a Th1 polarizing innate immune response in equine PBMC
por: Hellman, Stina, et al.
Publicado: (2018) -
Nanoparticulate Quillaja saponin induces apoptosis in human leukemia cell lines with a high therapeutic index
por: Hu, Kefei, et al.
Publicado: (2010) -
Cytokine responses to various larval stages of equine strongyles and modulatory effects of the adjuvant G3 in vitro
por: Hellman, Stina, et al.
Publicado: (2020) -
Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine
por: Cox, Freek, et al.
Publicado: (2015) -
Innate immune responses induced by the saponin adjuvant Matrix-M in specific pathogen free pigs
por: Ahlberg, Viktor, et al.
Publicado: (2017)